From new scientific data-sharing initiatives to US drug tariffs, May brought a range of major news to the pharma landscape.

Queen Camilla might be married to the king, but her sister Annabel Elliot still has a hard time thinking of her as royalty. 🎬SIGN UP for Parade's Daily newsletter to get the latest pop culture ...

Novo Nordisk (NYSE: NVO), the Danish drugmaker that's been riding high ever since it began putting out Ozempic and Wegovy GLP-1 injectables for treatment of diabetes and weight loss, got another ...

Novo Nordisk A/S (NVO) is a high-quality biopharma company that has been a growth play well before its recent obesity drug hit. Shares were hyped a while ago, but have now declined so much that ...

Taylor Maritime’s chief strategy officer, Camilla Pierrepont, has continued to buy shares in the bulker company after joining the board. A London Stock Exchange filing showed the director has ...

King Charles III and Queen Camilla attended the traditional Easter Sunday Matins service at St George’s Chapel in Windsor Castle, London, on April 20. The 76-year-old monarch who continues to ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind the groundbreaking GLP-1 weight loss drugs Ozempic and Wegovy, have been absolutely plummeting. The company's stock price slid over ...

Weight loss leader Novo Nordisk has had a poor performance at the stock markets year-to-date [YTD] even as the healthcare sector is among the least impacted ones. The key reason for this is ...

King Charles and Queen Camilla embraced supporters and appeared undeterred by protesters as they arrived for a Royal Maundy Service in Durham. Charles arrived at Durham Cathedral for the Maundy ...

Queen Camilla paid a sweet tribute to her late mother-in-law today, Queen Elizabeth II, as she attended the Maundy Service at Durham Cathedral with King Charles. Today, the King gave Maundy money ...

U.S.-listed shares of Novo Nordisk plunged 7% in intraday trading Thursday after rival Eli Lilly reported positive oral weight-loss drug news and BMO cut its rating for the Danish drug developer ...